ONK Therapeutics
Barna
About ONK Therapeutics
ONK Therapeutics is an innovative cell therapy company dedicated to developing the next generation of off-the-shelf, optimally engineered natural killer (NK) cell therapies targeting both hematological malignancies and solid tumors.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $21.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2022)
- Website: onktherapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/onk-therapeutics-25928 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.